The 19q13 KRAB Zinc-finger protein ZFP82 suppresses the growth and invasion of esophageal carcinoma cells through inhibiting NF-κB transcription and inducing apoptosis

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1 Zeng H, Zheng R, Zhang S et al. Esophageal cancer statistics in China, 2011: estimates based on 177 cancer registries. Thorac. Cancer 7(2), 232–237 (2016).
  MedlineGoogle Scholar
• 2 Deng J, Liang H, Ying G et al. Poor survival is associated with the methylated degree of zinc-finger protein 545 (ZNF545) DNA promoter in gastric cancer. Oncotarget 6(6), 4482–4495 (2015).
  MedlineGoogle Scholar
• 3 Fan Y, Zhan Q, Xu H et al. Epigenetic identification of ZNF545 as a functional tumor suppressor in multiple myeloma via activation of p53 signaling pathway. Biochem. Biophys. Res. Commun. 474(4), 660–666 (2016).
  Medline CASGoogle Scholar
• 4 Yang W, Yang S, Zhang M, Gao D, He T, Guo M. ZNF545 suppresses human hepatocellular carcinoma growth by inhibiting NF-κB signaling. Genes Cancer 8(3–4), 528–535 (2017).
  MedlineGoogle Scholar
• 5 Yu J, Li X, Tao Q et al. Hypermethylation of ZNF545 is associated with poor prognosis in patients with early-stage hepatocellular carcinoma after thermal ablation. Gut 64(11), 1836–1837 (2015).
  Medline CASGoogle Scholar
• 6 Brock MV, Gou M, Akiyama Y et al. Prognostic importance of promoter hypermethylation of multiple genes in esophageal adenocarcinoma. Clin. Cancer Res. 9(8), 2912–2919 (2003). •• Effects and mechanisms of ZFP82 in different cancers.
  Medline CASGoogle Scholar
• 7 Cheng Y, Liang P, Geng H et al. A novel 19q13 nucleolar zinc finger protein suppresses tumor cell growth through inhibiting ribosome biogenesis and inducing apoptosis but is frequently silenced in multiple carcinomas. Mol. Cancer Res. 10(7), 925–936 (2012).
  Medline CASGoogle Scholar
• 8 Lin Y, Bai L, Chen W, Xu S. The NF-kappaB activation pathways, emerging molecular targets for cancer prevention and therapy. Expert Opin. Ther. Targets 14(1), 45–55 (2010).
  Medline CASGoogle Scholar
• 9 May P, Soussi T. The role of p53 in normal cells and in cancer development. Pathologie Biologie 45(10), 781–784 (1997).
  Medline CASGoogle Scholar
• 10 Zare M, Jazii FR, Alivand MR, Nasseri NK, Malekzadeh R, Yazdanbod M. Qualitative analysis of Adenomatous Polyposis Coli promoter: hypermethylation, engagement and effects on survival of patients with esophageal cancer in a high risk region of the world, a potential molecular marker. BMC Cancer 9, 24 (2009).
  MedlineGoogle Scholar
• 11 Li C, Tang L, Zhao L et al. OPCML is frequently methylated in human colorectal cancer and its restored expression reverses EMT via downregulation of smad signaling. Am. J. Cancer Res. 5(5), 1635–1648 (2015). • Research methods used in this study.
  Medline CASGoogle Scholar
• 12 Li L, Ying J, Tong X et al. Epigenetic identification of receptor tyrosine kinase-like orphan receptor 2 as a functional tumor suppressor inhibiting beta-catenin and AKT signaling but frequently methylated in common carcinomas. Cell. Mol. Life Sci. 71(11), 2179–2192 (2014).
  Medline CASGoogle Scholar
• 13 Lee GY, Kenny PA, Lee EH, Bissell MJ. Three-dimensional culture models of normal and malignant breast epithelial cells. Nat. Methods 4(4), 359–365 (2007).
  Medline CASGoogle Scholar
• 14 Dolcet X, Llobet D, Pallares J, Matias-Guiu X. NF-κB in development and progression of human cancer. Virchows Arch. 446(5), 475–482 (2005).
  Medline CASGoogle Scholar
• 15 Xiao Y, Xiang T, Luo X et al. Zinc-finger protein 545 inhibits cell proliferation as a tumor suppressor through inducing apoptosis and is disrupted by promoter methylation in breast cancer. PLoS ONE 9(10), e110990 (2014).
  MedlineGoogle Scholar
• 16 Wang S, Cheng Y, Du W et al. Zinc-finger protein 545 is a novel tumour suppressor that acts by inhibiting ribosomal RNA transcription in gastric cancer. Gut 62(6), 833–841 (2013).
  Medline CASGoogle Scholar
• 17 Pahl HL. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18(49), 6853–6866 (1999).
  Medline CASGoogle Scholar
• 18 Ryazantseva NV, Novitskii VV, Zhukova OB et al. Role of NF-κB, p53, and p21 in the regulation of TNF-alpha mediated apoptosis of lymphocytes. Bull. Exp. Biol. Med. 149(1), 50–53 (2010).
  Medline CASGoogle Scholar
• 19 Bentires-Alj M, Dejardin E, Viatour P et al. Inhibition of the NF-kappa B transcription factor increases Bax expression in cancer cell lines. Oncogene 20(22), 2805–2813 (2001).
  Medline CASGoogle Scholar
• 20 Nakagawa Y, Sedukhina AS, Okamoto N et al. NF-kappaB signaling mediates acquired resistance after PARP inhibition. Oncotarget 6(6), 3825–3839 (2015).
  MedlineGoogle Scholar
• 21 Roy A, Banerjee S. p27 and leukemia: cell cycle and beyond. J. Cell. Physiol. 230(3), 504–509 (2015).
  Medline CASGoogle Scholar
• 22 Mirzayans R, Andrais B, Kumar P, Murray D. Significance of wild-type p53 signaling in suppressing apoptosis in response to chemical genotoxic agents: impact on chemotherapy outcome. Int. J. Mol. Sci. 18(5), e928 (2017).
  MedlineGoogle Scholar
• 23 Selivanova G, Wiman KG. Reactivation of mutant p53: molecular mechanisms and therapeutic potential. Oncogene 26(15), 2243–2254 (2007).
  Medline CASGoogle Scholar
• 24 Basile JR, Eichten A, Zacny V, Munger K. NF-kappaB-mediated induction of p21(Cip1/Waf1) by tumor necrosis factor alpha induces growth arrest and cytoprotection in normal human keratinocytes. Mol. Cancer Res. 1(4), 262–270 (2003). •• The NF-κB pathway and genes interacted with it, including genes related to apoptosis and cell cycle regulation.
  Medline CASGoogle Scholar